About Kala Biotech Private Limited
Data last updated: 07 March 2026
Kala Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It specialises in industrial compressors and pneumatic systems, a part of the broader machinery and industrial equipment sector. Incorporated on 30 September 2009, the company has been in operation for over 17 years.
Registered with ROC Pune under CIN U63000PN2009PTC134752.
Capital: an authorised share capital of ₹11.5 Cr and a paid-up capital of ₹9.48 Cr. It is led by directors including Sanjay Chandrakant Phutane and Kalawati Chandrakant Phutane.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 5 Talegaon Floriculture Park Midc Talegaon, Pune, Maharashtra, India – 410507.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.86 Cr, a growth of 27% compared to the previous year.
The company has a workforce of approximately 12 employees as per the latest available data.
As per MCA filings, the company has open charges of ₹10.34 Cr and satisfied charges of ₹4 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kalabiotech.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressPlot No. 5 Talegaon Floriculture Park Midc Talegaon, Pune, Maharashtra, India – 410507
-
IndustryMachinery and Equipment, Industrial Compressors & Pneumatic Systems
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Kala Biotech Private Limited
Kala Biotech Private Limited has one previous CIN (Corporate Identification Number): U01119PN2009PTC134752. The current CIN is U63000PN2009PTC134752, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U63000PN2009PTC134752 | Current |
| U01119PN2009PTC134752 | Previous |
Business Activity of Kala Biotech Private Limited
Kala Biotech Private Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including production of crops and animals.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A1 | Production of crops and animals | ********* |
Auditor Details of Kala Biotech Private Limited
Kala Biotech Private Limited is audited by S GAUTAM & ASSOCIATES for the financial year 2018. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S GAUTAM & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Kala Biotech Private Limited
Kala Biotech Private Limited is currently managed by 4 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sanjay Chandrakant Phutane
Also directs:
Kala Eco Green Energy Llp, Kmsp Farmers Producer Company Limited, Ksp Farmers Producer Company Limited and 3 more
|
Director | 30 Sep 2009 | 16 Years 9 Months | Current |
| Kalawati Chandrakant Phutane | Director | 30 Sep 2009 | 16 Years 9 Months | Current |
|
Praveen Chandrakant Phutane
Also directs:
Kala Care Global Llp, Kmsp Farmers Producer Company Limited, Ksp Farmers Producer Company Limited and 3 more
|
Director | 30 Sep 2009 | 16 Years 9 Months | Current |
|
Manoj Chandrakant Phutane
Also directs:
Innovision Realtors & Infrastructures Llp, Kala Care Global Llp, Kala Eco Green Energy Llp and 5 more
|
Director | 30 Sep 2009 | 16 Years 9 Months | Current |
Financials of Kala Biotech Private Limited FY 2025 filings available
Kala Biotech Private Limited reported revenue of ₹31.86 Cr (up 27% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Kala Biotech Private Limited
As of FY 2018, Kala Biotech Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Kala Biotech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2022 | Hdfc Bank Limited | ₹3.83 Cr | Open |
| 03 Sep 2022 | Hdfc Bank Limited | ₹6.5 Cr | Open |
| 28 May 2010 | Axis Bank Limited | ₹4 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Kala Biotech Private Limited
Kala Biotech Private Limited has a workforce of 12 employees as of Apr 07, 2024.
Employee Count & EPFO Data of Kala Biotech Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Kala Biotech Private Limited
GSTIN & GST Filing Data of Kala Biotech Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Kala Biotech Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Kala Biotech Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Kala Biotech Private Limited
MSME Payment Delays by Kala Biotech Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Kala Biotech Private Limited
Subsidiaries & Group Companies of Kala Biotech Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Kala Biotech Private Limited with ownership details.
MCA Filings & Documents of Kala Biotech Private Limited
MCA Filings & Documents of Kala Biotech Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Kala Biotech Private Limited
Frequently Asked Questions about Kala Biotech Private Limited
Kala Biotech Private Limited is an active private limited company in the machinery and equipment sector based in Pune, Maharashtra, India. It was incorporated on 30 September 2009 (17+ years old) and is registered under CIN U63000PN2009PTC134752. The company has 12 employees.
Kala Biotech Private Limited reported revenue of ₹31.86 Cr for FY 2025 (up 27.00% YoY).
The current directors of Kala Biotech Private Limited are:
The primary industry of Kala Biotech Private Limited is machinery and equipment. The company specifically operates in industrial compressors and pneumatic systems. The company is currently active in this sector.
Kala Biotech Private Limited can be reached at the registered office: Plot No. 5 Talegaon Floriculture Park Midc Talegaon, Pune, Maharashtra, India – 410507, or through the website kalabiotech.com.
The authorised capital is ₹11.5 Cr, and the paid-up capital is ₹9.48 Cr.